129 related articles for article (PubMed ID: 1980489)
1. Cyclic hexapeptides related to somatostatin. Synthesis and biological testing.
Pattaroni C; Lucietto P; Goodman M; Yamamoto G; Vale W; Moroder L; Gazerro L; Göhring W; Schmied B; Wünsch E
Int J Pept Protein Res; 1990 Nov; 36(5):401-17. PubMed ID: 1980489
[TBL] [Abstract][Full Text] [Related]
2. Cyclic hexapeptide analogs of somatostatin containing bridge modifications. Syntheses and conformational analyses.
Huang Z; Pröbstl A; Spencer JR; Yamazaki T; Goodman M
Int J Pept Protein Res; 1993 Oct; 42(4):352-65. PubMed ID: 7902342
[TBL] [Abstract][Full Text] [Related]
3. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biologic activity of conformationally constrained analogs of L-363,301.
Moore SB; Grant M; Rew Y; Bosa E; Fabbri M; Kumar U; Goodman M
J Pept Res; 2005 Dec; 66(6):404-22. PubMed ID: 16316457
[TBL] [Abstract][Full Text] [Related]
5. Conformational analyses by 1H NMR and computer simulations of cyclic hexapeptides related to somatostatin containing acidic and basic peptoid residues.
Mattern RH; Tran TA; Goodman M
J Pept Res; 1999 Feb; 53(2):146-60. PubMed ID: 10195452
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and binding potencies of cyclic hexapeptide analogs of somatostatin incorporating acidic and basic peptoid residues.
Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
J Pept Res; 1999 Feb; 53(2):134-45. PubMed ID: 10195451
[TBL] [Abstract][Full Text] [Related]
7. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues.
Mattern RH; Tran TA; Goodman M
J Pept Sci; 1999 Apr; 5(4):161-75. PubMed ID: 10323196
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
10. Absolute configuration for peptidomimetic residues in bioactive peptides.
Yamazaki T; Goodman M
Chirality; 1991; 3(4):268-76. PubMed ID: 1742164
[TBL] [Abstract][Full Text] [Related]
11. Topochemical design of bioactive peptides and peptidomimetics.
Goodman M; Ro S; Yamazaki T; Spencer JR; Toy A; Huang Z; He Y; Reisine T
Bioorg Khim; 1992; 18(10-11):1375-93. PubMed ID: 1363715
[TBL] [Abstract][Full Text] [Related]
12. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
13. Conformational analyses of somatostatin-related cyclic hexapeptides containing peptoid residues.
Mattern RH; Tran TA; Goodman M
J Med Chem; 1998 Jul; 41(15):2686-92. PubMed ID: 9667959
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin analogs with improved oral bioavailability.
Nutt RF; Colton CD; Veber DF; Slater EL; Saperstein R
Klin Wochenschr; 1986; 64 Suppl 7():71-3. PubMed ID: 2882053
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues.
Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556
[TBL] [Abstract][Full Text] [Related]
16. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
17. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
18. Development of specific and non-specific somatostatin analogs.
Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y
Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological activity and conformational study of a somatostatin hexapeptide analogue containing a reduced peptide bond.
Delaet NG; Verheyden P; Velkeniers B; Hooghe-Peters EL; Bruns C; Tourwé D; Van Binst G
Pept Res; 1993; 6(1):24-30. PubMed ID: 8094990
[TBL] [Abstract][Full Text] [Related]
20. Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSST2 and hSST4. An unexpected effect of the chirality of Trp8 on NMR spectra in methanol.
Neelamkavil S; Arison B; Birzin E; Feng JJ; Chen KH; Lin A; Cheng FC; Taylor L; Thornton ER; Smith AB; Hirschmann R
J Med Chem; 2005 Jun; 48(12):4025-30. PubMed ID: 15943475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
